Understanding the Relationship Between Care Volume and Clinical Outcomes in Multiple Myeloma.
作者信息
Halm Ethan A, Anderson Larry D, Gerber David E
机构信息
Ethan A. Halm, Larry D. Anderson Jr, and David E. Gerber, University of Texas Southwestern Medical Center, Dallas, TX.
出版信息
J Clin Oncol. 2017 Feb 20;35(6):580-582. doi: 10.1200/JCO.2016.70.4726. Epub 2017 Jan 17.
Abstract
摘要
相似文献
1
Understanding the Relationship Between Care Volume and Clinical Outcomes in Multiple Myeloma.了解多发性骨髓瘤的治疗量与临床结果之间的关系。
J Clin Oncol. 2017 Feb 20;35(6):580-582. doi: 10.1200/JCO.2016.70.4726. Epub 2017 Jan 17.
2
Equal Treatment and Outcomes for Everyone with Multiple Myeloma: Are We There Yet?多发性骨髓瘤患者人人享有平等治疗与结局：我们做到了吗？
Curr Hematol Malig Rep. 2017 Aug;12(4):309-316. doi: 10.1007/s11899-017-0393-y.
3
Dynamic interplay between bone and multiple myeloma: emerging roles of the osteoblast.骨骼与多发性骨髓瘤之间的动态相互作用：成骨细胞的新作用
Bone. 2015 Jun;75:161-9. doi: 10.1016/j.bone.2015.02.021. Epub 2015 Feb 26.
4
Clinical perspective: Linking psychosocial care to the disease continuum in patients with multiple myeloma.临床视角：将心理社会护理与多发性骨髓瘤患者的疾病连续体相联系。
Palliat Support Care. 2015 Aug;13(4):829-38. doi: 10.1017/S1478951514000649. Epub 2014 Jun 24.
5
Vaccination in Multiple Myeloma: Review of Current Literature.多发性骨髓瘤的疫苗接种：当前文献综述
Clin Lymphoma Myeloma Leuk. 2016 Sep;16(9):495-502. doi: 10.1016/j.clml.2016.06.006. Epub 2016 Jun 8.
6
[Pathological Characteristics of Bone Marrow in Multiple Myeloma Patients with Secondary Myelofibrosis and Their Relationship with Prognosis].[继发性骨髓纤维化的多发性骨髓瘤患者骨髓的病理特征及其与预后的关系]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Aug;25(4):1080-1085. doi: 10.7534/j.issn.1009-2137.2017.04.021.
7
Clinical roundtable monograph. Emerging treatment options for relapsed and refractory multiple myeloma.临床圆桌会议专论。复发难治性多发性骨髓瘤的新兴治疗选择
Clin Adv Hematol Oncol. 2011 Apr;9(4):1-15.
8
Distress, Fatigue, and Sexuality: Understanding and Treating Concerns and Symptoms in Patients With Multiple Myeloma
.痛苦、疲劳与性：理解与治疗多发性骨髓瘤患者的相关问题及症状
Clin J Oncol Nurs. 2017 Oct 1;21(5 Suppl):7-18. doi: 10.1188/17.CJON.S5.7-18.
9
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: biological insights and early treatment strategies.意义未明的单克隆丙种球蛋白病和冒烟型多发性骨髓瘤：生物学见解与早期治疗策略
Hematology Am Soc Hematol Educ Program. 2013;2013:478-87. doi: 10.1182/asheducation-2013.1.478.
10
Molecular pathogenesis of multiple myeloma.多发性骨髓瘤的分子发病机制
Hematol Oncol Clin North Am. 2007 Dec;21(6):985-1006, vii. doi: 10.1016/j.hoc.2007.08.004.
引用本文的文献
1
Differences in Cancer Care Expenditures and Utilization for Surgery by Hospital Type Among Patients With Private Insurance.私人保险患者的手术费用和利用的医院类型的癌症护理支出的差异。
JAMA Netw Open. 2021 Aug 2;4(8):e2119764. doi: 10.1001/jamanetworkopen.2021.19764.
2
Trends in Patient Volume by Hospital Type and the Association of These Trends With Time to Cancer Treatment Initiation.医院类型的患者量趋势及这些趋势与癌症治疗启动时间的关联。
JAMA Netw Open. 2021 Jul 1;4(7):e2115675. doi: 10.1001/jamanetworkopen.2021.15675.
3
Should we pay attention to surgeon or hospital volume in total knee arthroplasty? Evidence from a nationwide population-based study.我们应该关注全膝关节置换术的外科医生还是医院的数量？一项全国范围内基于人群的研究证据。
PLoS One. 2019 May 10;14(5):e0216667. doi: 10.1371/journal.pone.0216667. eCollection 2019.
本文引用的文献
1
Association Between Treatment Facility Volume and Mortality of Patients With Multiple Myeloma.多发性骨髓瘤患者的治疗机构容量与死亡率之间的关联。
J Clin Oncol. 2017 Feb 20;35(6):598-604. doi: 10.1200/JCO.2016.68.3805. Epub 2016 Oct 23.
2
Optimizing Treatment for Elderly Patients With Newly Diagnosed Multiple Myeloma: A Personalized Approach.优化新诊断多发性骨髓瘤老年患者的治疗：一种个性化方法。
J Clin Oncol. 2016 Oct 20;34(30):3600-3604. doi: 10.1200/JCO.2016.68.6113.
3
Hospital volume and acute myeloid leukemia mortality in Medicare beneficiaries aged 65 years and older.65岁及以上医疗保险受益人的医院就诊量与急性髓系白血病死亡率
Blood. 2016 Aug 11;128(6):872-4. doi: 10.1182/blood-2016-05-716662. Epub 2016 Jun 29.
4
Influence of the treatment facility volume on the survival of patients with non-Hodgkin lymphoma.治疗机构规模对非霍奇金淋巴瘤患者生存率的影响。
Cancer. 2016 Aug 15;122(16):2552-9. doi: 10.1002/cncr.30038. Epub 2016 May 16.
5
Annual Hospital Volume of High Dose Interleukin-2 and Inpatient Mortality in Melanoma and Renal Cell Carcinoma Patients.黑色素瘤和肾细胞癌患者高剂量白细胞介素-2的年度医院使用量与住院死亡率
PLoS One. 2016 Jan 22;11(1):e0147153. doi: 10.1371/journal.pone.0147153. eCollection 2016.
6
Impact of hospital volume on outcomes of patients undergoing chemotherapy for acute myeloid leukemia: a matched cohort study.医院规模对急性髓系白血病化疗患者结局的影响：一项匹配队列研究。
Blood. 2015 May 21;125(21):3359-60. doi: 10.1182/blood-2015-01-625764.
7
Why do high-volume hospitals achieve better outcomes? A systematic review about intermediate factors in volume-outcome relationships.为什么高容量医院能取得更好的治疗效果？关于容量-效果关系中间因素的系统评价。
Health Policy. 2015 Aug;119(8):1055-67. doi: 10.1016/j.healthpol.2015.04.005. Epub 2015 Apr 18.
8
Hospital volume and operative mortality in the modern era.现代医院的手术量与手术死亡率
Ann Surg. 2014 Aug;260(2):244-51. doi: 10.1097/SLA.0000000000000375.
9
Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).血液学家/肿瘤学家的疾病专业知识与生存：慢性淋巴细胞白血病（CLL）/小淋巴细胞淋巴瘤（SLL）的经验教训。
Cancer. 2012 Apr 1;118(7):1827-37. doi: 10.1002/cncr.26474. Epub 2011 Aug 26.
10
Hospital volume and failure to rescue with high-risk surgery.医院手术量与高危手术的抢救失败。
Med Care. 2011 Dec;49(12):1076-81. doi: 10.1097/MLR.0b013e3182329b97.
Zotero 插件